Stay updated on Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:58:36.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added the Hepatocellular carcinoma tag, added a resource link to the Genetic and Rare Diseases Information Center, and updated the site revision from 3.4.3 to 3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T15:45:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No user-facing content changes are evident.
    Difference
    0.1%
    Check dated 2026-03-11T16:41:01.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Deleted notices include a government funding status warning and the prior site revision note (v3.4.1); a new site revision (v3.4.2) has been added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T06:14:56.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a site-wide funding/status notice and the page revision tag v3.4.1, and removed the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:19:02.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and new metadata lines (Last Update Submitted that Met QC Criteria; Revision: v3.4.0; No FEAR Act Data). The older QC criterion line and the previous No FEAR Act data wording were removed or changed.
    Difference
    0.2%
    Check dated 2026-01-28T04:22:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.